Metabolomics in Sepsis and Its Impact on Public Health

Sepsis, with its often devastating consequences for patients and their families, remains a major public health concern that poses an increasing financial burden. Early resuscitation together with the elucidation of the biological pathways and pathophysiological mechanisms with the use of “-omics” technologies have started changing the clinical and research landscape in sepsis. Metabolomics (i.e., the study of the metabolome), an “-omics” technology further down in the “-omics” cascade between the genome and the phenome, could be particularly fruitful in sepsis research with the potential to alter the clinical practice. Apart from its benefit for the individual patient, metabolomics has an impact on public health that extends beyond its applications in medicine. In this review, we present recent developments in metabolomics research in sepsis, with a focus on pneumonia, and we discuss the impact of metabolomics on public health, with a focus on free/libre open source software.

[1]  Alla Karnovsky,et al.  Whole Blood Reveals More Metabolic Detail of the Human Metabolome than Serum as Measured by 1H-NMR Spectroscopy: Implications for Sepsis Metabolomics , 2015, Shock.

[2]  M. Bauer,et al.  Metabolite Profiles in Sepsis: Developing Prognostic Tools Based on the Type of Infection* , 2016, Critical care medicine.

[3]  H. Wong.  Clinical review: Sepsis and septic shock - the potential of gene arrays , 2012, Critical Care.

[4]  Michael C Scott.  Defining and Diagnosing Sepsis. , 2017, Emergency medicine clinics of North America.

[5]  David J. States,et al.  Bioinformatics Applications Note Databases and Ontologies Metab2mesh: Annotating Compounds with Medical Subject Headings , 2022 .

[6]  Royston Goodacre,et al.  Systems level studies of mammalian metabolomes: the roles of mass spectrometry and nuclear magnetic resonance spectroscopy. , 2011, Chemical Society reviews.

[7]  Alberto Cambrosio,et al.  Biomedical Platforms: Realigning the Normal and the Pathological in Late-Twentieth-Century Medicine , 2003 .

[8]  Kathleen A Stringer,et al.  The emerging field of quantitative blood metabolomics for biomarker discovery in critical illnesses. , 2011, American journal of respiratory and critical care medicine.

[9]  J. Eiros,et al.  Transcriptomic correlates of organ failure extent in sepsis. , 2015, The Journal of infection.

[10]  E. Antman,et al.  Cytochrome p-450 polymorphisms and response to clopidogrel. , 2009, The New England journal of medicine.

[11]  N. Dean,et al.  Severe community-acquired pneumonia: timely management measures in the first 24 hours , 2016, Critical Care.

[12]  P. Schuetz,et al.  Systematic review regarding metabolic profiling for improved pathophysiological understanding of disease and outcome prediction in respiratory infections , 2015, Respiratory Research.

[13]  Kwanjeera Wanichthanarak,et al.  MetaMapR: pathway independent metabolomic network analysis incorporating unknowns , 2015, Bioinform..

[14]  A. Brand,et al.  Public Health Genomics: the essential part for good governance in public health , 2016, International Journal of Public Health.

[15]  Eirini Christaki,et al.  The beginning of personalized medicine in sepsis: small steps to a bright future , 2014, Clinical genetics.

[16]  Cisca Wijmenga,et al.  A Meta-Analysis of Genome-Wide Association Scans Identifies IL18RAP, PTPN2, TAGAP, and PUS10 As Shared Risk Loci for Crohn's Disease and Celiac Disease , 2011, PLoS genetics.

[17]  H. Vogel,et al.  Metabolomics as a novel approach for early diagnosis of pediatric septic shock and its mortality. , 2013, American journal of respiratory and critical care medicine.

[18]  C. Hohenstein,et al.  Die goldene Stunde der Sepsis , 2014, Medizinische Klinik - Intensivmedizin und Notfallmedizin.

[19]  M. Younis,et al.  Hospital-related cost of sepsis: A systematic review. , 2017, The Journal of infection.

[20]  I. Androulakis,et al.  Temporal Metabolic Profiling of Plasma During Endotoxemia in Humans , 2013, Shock.

[21]  C. Woods,et al.  What was old is new again: using the host response to diagnose infectious disease , 2015, Expert review of molecular diagnostics.

[22]  W. McGee,et al.  The Economic and Humanistic Burden of Severe Sepsis , 2015, PharmacoEconomics.

[23]  A. Zhang,et al.  A Functional Variant of Lipopolysaccharide Binding Protein Predisposes to Sepsis and Organ Dysfunction in Patients with Major Trauma , 2012, Annals of surgery.

[24]  Zoltán Kutalik,et al.  Quality control and conduct of genome-wide association meta-analyses , 2014, Nature Protocols.

[25]  T. Marrie,et al.  Streptococcus pneumoniae and Staphylococcus aureus pneumonia induce distinct metabolic responses. , 2009, Journal of proteome research.

[26]  Uli K. Chettipally,et al.  Prediction of Sepsis in the Intensive Care Unit With Minimal Electronic Health Record Data: A Machine Learning Approach , 2016, JMIR medical informatics.

[27]  Timothy D Veenstra,et al.  Metabolomics: the final frontier? , 2012, Genome Medicine.

[28]  P. Schlattmann,et al.  Procalcitonin-guided therapy in intensive care unit patients with severe sepsis and septic shock – a systematic review and meta-analysis , 2013, Critical Care.

[29]  R. Carlson,et al.  Maternal Sepsis and Septic Shock. , 2016, Critical care clinics.

[30]  H. Grundmann,et al.  Molecular epidemiology of human pathogens: how to translate breakthroughs into public health practice, Stockholm, November 2011. , 2012, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[31]  Stephanie J. Reisinger,et al.  An Integrated Clinico-Metabolomic Model Improves Prediction of Death in Sepsis , 2013, Science Translational Medicine.

[32]  V. Coba,et al.  Management of sepsis: early resuscitation. , 2008, Clinics in chest medicine.

[33]  S. Ebrahim,et al.  Epigenetics: the next big thing. , 2012, International journal of epidemiology.

[34]  Xuan-xian Peng,et al.  Liver functional metabolomics discloses an action of L-leucine against Streptococcus iniae infection in tilapias. , 2015, Fish & shellfish immunology.

[35]  M. Matthay,et al.  Applying metabolomics to uncover novel biology in ARDS. , 2014, American journal of physiology. Lung cellular and molecular physiology.

[36]  Anthony F Massaro,et al.  Diagnosing sepsis is subjective and highly variable: a survey of intensivists using case vignettes , 2016, Critical Care.

[37]  M. Levy,et al.  Empiric Antibiotic Treatment Reduces Mortality in Severe Sepsis and Septic Shock From the First Hour: Results From a Guideline-Based Performance Improvement Program* , 2014, Critical care medicine.

[38]  Anna Lindahl,et al.  Overlap in serum metabolic profiles between non-related diseases: Implications for LC-MS metabolomics biomarker discovery. , 2016, Biochemical and biophysical research communications.

[39]  A. Gordon,et al.  Metabonomics and intensive care , 2016, Critical Care.

[40]  Donatella,et al.  A Meta-Analysis of Genome-Wide Association Scans Identifies IL18RAP, PTPN2, TAGAP, and PUS10 As Shared Risk Loci for Crohn's Disease and Celiac Disease , 2011, PLoS genetics.

[41]  R. Bellomo,et al.  The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). , 2016, JAMA.

[42]  D. Wishart.  Emerging applications of metabolomics in drug discovery and precision medicine , 2016, Nature Reviews Drug Discovery.

[43]  Mark Earll,et al.  Open source software for mass spectrometry and metabolomics , 2012 .

[44]  D. Wishart.  Advances in metabolite identification. , 2011, Bioanalysis.

[45]  Mitchell M. Levy,et al.  A Framework for the Development and Interpretation of Different Sepsis Definitions and Clinical Criteria , 2016, Critical care medicine.

[46]  Vance G. Fowler,et al.  Metabolomic Derangements Are Associated with Mortality in Critically Ill Adult Patients , 2014, PloS one.

[47]  L. Srinivasan,et al.  Elucidating the role of genomics in neonatal sepsis. , 2015, Seminars in perinatology.

[48]  P. Elliott,et al.  Assessment of analytical reproducibility of 1H NMR spectroscopy based metabonomics for large-scale epidemiological research: the INTERMAP Study. , 2006, Analytical chemistry.

[49]  Guangdong Shao,et al.  Metabolomic approach for the identification of therapeutic targets of erythropoietin against sepsis in rat models. , 2016, European review for medical and pharmacological sciences.

[50]  F. V. van Haren,et al.  Fluid resuscitation in human sepsis: Time to rewrite history? , 2017, Annals of Intensive Care.

[51]  C. Bonorino,et al.  CD14 Expression in the First 24h of Sepsis: Effect of −260C>T CD14 SNP , 2008, Immunological investigations.

[52]  John D. Storey,et al.  A network-based analysis of systemic inflammation in humans , 2005, Nature.

[53]  Jeremy J. Ramsden,et al.  Bioinformatics: An Introduction , 2004, Computational Biology.

[54]  Todd A. Johnson,et al.  A genome-wide association study identifies 2 susceptibility Loci for Crohn's disease in a Japanese population. , 2013, Gastroenterology.

[55]  T. Chaudhary,et al.  [The golden hour of sepsis: initial therapy should start in the prehospital setting]. , 2014, Medizinische Klinik, Intensivmedizin und Notfallmedizin.

[56]  F. Herrero,et al.  Microbiology and Risk Factors for Community-Acquired Pneumonia , 2012, Seminars in Respiratory and Critical Care Medicine.

[57]  Mark J. Forster,et al.  Open source software in life science research: Practical solutions to common challenges in the pharmaceutical industry and beyond , 2012 .

[58]  Ian D. Wilson,et al.  Metabolic Phenotyping in Health and Disease , 2008, Cell.

[59]  Daniel Monleon,et al.  Prognosis Biomarkers of Severe Sepsis and Septic Shock by 1H NMR Urine Metabolomics in the Intensive Care Unit , 2015, PloS one.

[60]  L. Holm,et al.  Genomics and Proteomics Provide New Insight into the Commensal and Pathogenic Lifestyles of Bovine- and Human-Associated Staphylococcus epidermidis Strains. , 2014, Journal of proteome research.

[61]  J. Rello,et al.  Nosocomial pneumonia in 27 ICUs in Europe: perspectives from the EU-VAP/CAP study , 2016, European Journal of Clinical Microbiology & Infectious Diseases.

[62]  Dana C. Crawford,et al.  Unravelling the human genome–phenome relationship using phenome-wide association studies , 2016, Nature Reviews Genetics.

[63]  J. Englert,et al.  Metabolism, Metabolomics, and Nutritional Support of Patients with Sepsis. , 2016, Clinics in chest medicine.

[64]  A. Brand,et al.  Personalized health in a public health perspective , 2018, International Journal of Public Health.

[65]  David S. Wishart,et al.  HMDB 3.0—The Human Metabolome Database in 2013 , 2012, Nucleic Acids Res..

[66]  G. Abecasis,et al.  A Genome-Wide Association Study of Type 2 Diabetes in Finns Detects Multiple Susceptibility Variants , 2007, Science.

[67]  M. Howell,et al.  Quick Sepsis‐related Organ Failure Assessment, Systemic Inflammatory Response Syndrome, and Early Warning Scores for Detecting Clinical Deterioration in Infected Patients outside the Intensive Care Unit , 2017, American journal of respiratory and critical care medicine.

[68]  David S Wishart,et al.  Computational approaches to metabolomics. , 2010, Methods in molecular biology.

[69]  Joel B. Hagen,et al.  The origins of bioinformatics , 2000, Nature Reviews Genetics.

[70]  J. L. Izquierdo-García,et al.  A metabolomic approach for diagnosis of experimental sepsis , 2011, Intensive Care Medicine.

[71]  Tariq Ahmad,et al.  Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci , 2010, Nature Genetics.

[72]  H. Vogel,et al.  Metabolomic Profiling in Cattle Experimentally Infected with Mycobacterium avium subsp. paratuberculosis , 2014, PloS one.

[73]  Ian M. Mitchell,et al.  Reproducible research for scientific computing: Tools and strategies for changing the culture , 2012, Computing in Science & Engineering.

[74]  Lars Malmström,et al.  Large-scale inference of protein tissue origin in gram-positive sepsis plasma using quantitative targeted proteomics , 2016, Nature Communications.

[75]  R. Guthke,et al.  Differential Biphasic Transcriptional Host Response Associated with Coevolution of Hemagglutinin Quasispecies of Influenza A Virus , 2016, Frontiers in Microbiology.

[76]  Toshihiro Tanaka.  The International HapMap Project , 2003, Nature.

[77]  R. A. Robinson,et al.  The role of proteomics in understanding biological mechanisms of sepsis , 2014, Proteomics. Clinical applications.

[78]  Bob Miller,et al.  Towards a Framework for Managing the Information Environment , 2001, Inf. Knowl. Syst. Manag..

[79]  Hans Weda,et al.  Exhaled Breath Metabolomics for the Diagnosis of Pneumonia in Intubated and Mechanically-Ventilated Intensive Care Unit (ICU)-Patients , 2017, International journal of molecular sciences.

[80]  Da-zhen Peng,et al.  Sepsis biomarkers: an omics perspective , 2014, Frontiers of Medicine.

[81]  Kimberly Pelak,et al.  A genome-wide association study of variants associated with acquisition of Staphylococcus aureus bacteremia in a healthcare setting , 2014, BMC Infectious Diseases.

[82]  G. O’Keefe,et al.  Toll-Like Receptor 1 Polymorphisms and Associated Outcomes in Sepsis After Traumatic Injury: A Candidate Gene Association Study , 2014, Annals of surgery.

[83]  A. Ellrodt,et al.  Sepsis and septic shock. , 1986, Emergency medicine clinics of North America.

[84]  J. Crawford,et al.  Acyl Histidines: New N‐Acyl Amides from Legionella pneumophila , 2017, Chembiochem : a European journal of chemical biology.

[85]  H. Alam,et al.  Modulation of Acetylation: Creating a Pro-survival and Anti-Inflammatory Phenotype in Lethal Hemorrhagic and Septic Shock , 2011, Journal of biomedicine & biotechnology.

[86]  Christian Gieger,et al.  Combined analysis of genome-wide association studies for Crohn disease and psoriasis identifies seven shared susceptibility loci. , 2012, American journal of human genetics.

[87]  Michael A Puskarich,et al.  Metabolomics as a Driver in Advancing Precision Medicine in Sepsis , 2017, Pharmacotherapy.

[88]  Samson S. Y. Wong,et al.  Lipid mediators of inflammation as novel plasma biomarkers to identify patients with bacteremia. , 2015, The Journal of infection.

[89]  H. P. Leite,et al.  Metabolic resuscitation in sepsis: a necessary step beyond the hemodynamic? , 2016, Journal of thoracic disease.

[90]  H. Vogel,et al.  Characterization and prediction of the mechanism of action of antibiotics through NMR metabolomics , 2016, BMC Microbiology.

[91]  A. Brand,et al.  The impact of genetics and genomics on public health , 2008, European Journal of Human Genetics.

[92]  R. Tompkins,et al.  A Small Volatile Bacterial Molecule Triggers Mitochondrial Dysfunction in Murine Skeletal Muscle , 2013, PloS one.

[93]  Samson S. Y. Wong,et al.  Lipid metabolites as potential diagnostic and prognostic biomarkers for acute community acquired pneumonia , 2016, Diagnostic Microbiology and Infectious Disease.

[94]  J. Hunt,et al.  TLR4 and TNF-α polymorphisms are associated with an increased risk for severe sepsis following burn injury , 2004, Journal of Medical Genetics.

[95]  M. Friedrich,et al.  Scientists seek to sniff out diseases: electronic "noses" may someday be diagnostic tools. , 2009, JAMA.

[96]  Samir S. Shah,et al.  Emerging Biomarkers of Illness Severity: Urinary Metabolites Associated with Sepsis and Necrotizing Methicillin‐Resistant Staphylococcus aureus Pneumonia , 2017, Pharmacotherapy.

[97]  K. Walley,et al.  The association of interleukin 6 haplotype clades with mortality in critically ill adults. , 2005, Archives of internal medicine.

[98]  J. D. Watson,et al.  Human Genome Project: Twenty-five years of big biology , 2015, Nature.

[99]  Sirish L. Shah,et al.  Pneumococcal pneumonia: potential for diagnosis through a urinary metabolic profile. , 2009, Journal of proteome research.

[100]  A. Karnovsky,et al.  Pharmacometabolomics of l-carnitine treatment response phenotypes in patients with septic shock. , 2015, Annals of the American Thoracic Society.

[101]  Christian Gieger,et al.  Mining the Unknown: A Systems Approach to Metabolite Identification Combining Genetic and Metabolic Information , 2012, PLoS genetics.

[102]  Christopher W Seymour,et al.  Developing a New Definition and Assessing New Clinical Criteria for Septic Shock: For the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). , 2016, JAMA.